Published in Arzneimittelforschung on February 01, 1975
Teichomycin: in-vitro and in-vivo evaluation in comparison with other antibiotics. J Antimicrob Chemother (1983) 2.52
Multicenter comparison of ESP Culture System II with BACTEC 460TB and with Lowenstein-Jensen medium for recovery of mycobacteria from different clinical specimens, including blood. J Clin Microbiol (1998) 2.16
Biliary excretion of antibiotics in man. Gut (1968) 2.15
Teichomycins, new antibiotics from Actinoplanes teichomyceticus nov. sp. IV. Separation and characterization of the components of teichomycin (teicoplanin). J Antibiot (Tokyo) (1984) 1.76
Teicoplanin-resistant coagulase-negative staphylococci. Lancet (1987) 1.69
Rifampicin: a new rifamycin. 3. Absorption, distribution, and elimination in man. Arzneimittelforschung (1967) 1.57
Rifampicin: a new rifamycin. I. Bacteriological studies. Arzneimittelforschung (1967) 1.54
Relationships between bactericidal effect and inhibition of ribonucleic acid nucleotidyltransferase by rifampicin in Escherichia coli K-12. J Bacteriol (1969) 1.47
Outcome and lineage involvement in t(12;21) childhood acute lymphoblastic leukaemia. Br J Haematol (1997) 1.45
Rifampicin: a new rifamycin. II. Laboratory studies on the antituberculous activity and preliminary clinical observations. Arzneimittelforschung (1967) 1.45
A40926, a new glycopeptide antibiotic with anti-Neisseria activity. Antimicrob Agents Chemother (1987) 1.42
Ramoplanin (A-16686), a new glycolipodepsipeptide antibiotic. III. Structure elucidation. J Antibiot (Tokyo) (1989) 1.41
Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients. Leukemia (2002) 1.39
Synthesis and biological properties of N63-carboxamides of teicoplanin antibiotics. Structure-activity relationships. J Med Chem (1989) 1.26
A new locus for autosomal recessive hereditary spastic paraplegia maps to chromosome 16q24.3. Am J Hum Genet (1998) 1.25
A-16686, a new antibiotic from Actinoplanes. I. Fermentation, isolation and preliminary physico-chemical characteristics. J Antibiot (Tokyo) (1984) 1.20
In vitro bacteriological studies on rifamycin B diethylamide (rifamide). Arzneimittelforschung (1965) 1.15
Teicoplanin, antibiotics from Actinoplanes teichomyceticus nov. sp. VI. Chemical degradation: physico-chemical and biological properties of acid hydrolysis products. J Antibiot (Tokyo) (1984) 1.13
A-16686, a new antibiotic from Actinoplanes. II. Biological properties. J Antibiot (Tokyo) (1984) 1.13
Elliptic flow of charged particles in Pb-Pb collisions at sqrt[S(NN)] = 2.76 TeV. Phys Rev Lett (2010) 1.12
Particle-yield modification in jetlike azimuthal dihadron correlations in Pb-Pb collisions at √s(NN)=2.76 TeV. Phys Rev Lett (2012) 1.11
Environmental and genetic risk factors in Parkinson's disease: a case-control study in southern Italy. Mov Disord (1996) 1.11
Distribution of human herpesvirus-8 sequences throughout the spectrum of AIDS-related neoplasia. AIDS (1996) 1.08
Transverse momentum distribution and nuclear modification factor of charged particles in p+Pb collisions at sqrt[s(NN)] = 5.02 TeV. Phys Rev Lett (2013) 1.08
New derivatives of rifamycin SV. Antimicrob Agents Chemother (Bethesda) (1965) 1.07
Prenatal diagnosis and outcome of fetal posterior fossa fluid collections. Ultrasound Obstet Gynecol (2012) 1.07
Higher harmonic anisotropic flow measurements of charged particles in Pb-Pb collisions at sqrt(s(NN)) = 2.76 TeV. Phys Rev Lett (2011) 1.05
Dissection of pathways implicated in integrin-mediated actin cytoskeleton assembly. Involvement of protein kinase C, Rho GTPase, and tyrosine phosphorylation. J Biol Chem (1997) 1.01
Synthesis and biological activity of some derivatives of rifamycin P. J Med Chem (1990) 1.01
[Hydroxylamides of penicillin V]. Farmaco Sci (1966) 1.00
Integrin-mediated signal transduction in human endothelial cells: analysis of tyrosine phosphorylation events. Cell Adhes Commun (1994) 0.99
Production of muons from heavy flavor decays at forward rapidity in pp and Pb-Pb collisions at sqrt[s(NN)]=2.76 TeV. Phys Rev Lett (2012) 0.98
[Synthesis of ethyl alpha-fluoroarylacetates]. Farmaco Sci (1970) 0.96
Macrolide resistance in group A streptococci. J Antimicrob Chemother (2000) 0.93
Centrality dependence of the charged-particle multiplicity density at midrapidity in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2011) 0.93
Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: clinical relevance in 71 patients. Ann Oncol (1998) 0.91
New 5-substituted 1-alkyl-2-nitroimidazoles. J Med Chem (1973) 0.89
Trastuzumab-induced myocardiotoxicity mimicking acute coronary syndrome. Case Rep Oncol (2012) 0.89
Ramoplanin: a review of its discovery and its chemistry. Drugs Exp Clin Res (1990) 0.88
Distribution of Kaposi's sarcoma herpesvirus sequences among lymphoid malignancies in Italy and Spain. Br J Haematol (1995) 0.88
Streptococcus pyogenes collected in Torino (northwest Italy) between 1983 and 1998: survey of macrolide resistance and trend of genotype by RAPD. Microb Drug Resist (2000) 0.88
Synthesis and biological activity of some amide derivatives of the lantibiotic actagardine. J Antibiot (Tokyo) (1990) 0.88
Dementia, ataxia, extrapyramidal features, and epilepsy: phenotype spectrum in two Italian families with spinocerebellar ataxia type 17. Neurol Sci (2003) 0.88
The mechanism of action of nitro-heterocyclic antimicrobial drugs. Metabolic activation by micro-organisms. J Gen Microbiol (1977) 0.88
Interaction between the G1057D variant of IRS-2 and overweight in the pathogenesis of type 2 diabetes. Hum Mol Genet (2000) 0.88
Midrapidity antiproton-to-proton ratio in pp collisons at sqrt[s]=0.9 and 7 TeV measured by the ALICE experiment. Phys Rev Lett (2010) 0.87
The alpha-synuclein Ala53Thr mutation is not a common cause of familial Parkinson's disease: a study of 230 European cases. European Consortium on Genetic Susceptibility in Parkinson's Disease. Ann Neurol (1998) 0.87
Sequencing of the alpha-synuclein gene in a large series of cases of familial Parkinson's disease fails to reveal any further mutations. The European Consortium on Genetic Susceptibility in Parkinson's Disease (GSPD). Hum Mol Genet (1998) 0.87
Ultrasonic diagnosis and perinatal management of complicated and uncomplicated fetal ovarian cysts: a collaborative study. J Perinat Med (1990) 0.87
Desacetyl-rifamycins: preparation and antibacterial properties. Experientia (1968) 0.86
Brainstem-vermis and brainstem-tentorium angles allow accurate categorization of fetal upward rotation of cerebellar vermis. Ultrasound Obstet Gynecol (2012) 0.86
Increasing frequency of multiple sclerosis in Padova, Italy: a 30 year epidemiological survey. Mult Scler (2003) 0.85
Synthesis and biological activity of new 2-nitroimidazole derivatives. J Med Chem (1978) 0.85
Synthesis and antibacterial activity of a series of basic amides of teicoplanin and deglucoteicoplanin with polyamines. J Med Chem (1992) 0.85
Human herpesvirus type-8 (HHV-8) in haematopoietic neoplasia. Leuk Lymphoma (1997) 0.84
Thioureas and isothiouronium salts of the aglycone of teicoplanin. I. Synthesis and biological activity. J Antibiot (Tokyo) (1989) 0.84
Rifampicin and immunosuppression. Arzneimittelforschung (1974) 0.84
Synthesis and biological evaluation of de(acetylglucosaminyl)didehydrodeoxy derivatives of teicoplanin antibodies. J Med Chem (1989) 0.83
Distinct regulation of c-myb gene expression by HoxA9, Meis1 and Pbx proteins in normal hematopoietic progenitors and transformed myeloid cells. Blood Cancer J (2012) 0.83
Rifampicin desacetylation in the human organism. Arzneimittelforschung (1969) 0.83
Teicoplanin: chemical, physico-chemical and biological aspects. Farmaco Sci (1987) 0.83
Comparative evaluation between cervical vertebral morphology and hand-wrist morphology for skeletal maturation assessment. Minerva Stomatol (2006) 0.82
Teicoplanin, antibiotics from Actinoplanes teichomyceticus nov. sp. VII. Preparation and NMR characteristics of the aglycone of teicoplanin. J Antibiot (Tokyo) (1986) 0.82
J/ψ elliptic flow in Pb-Pb collisions at √(s(NN))=2.76 TeV. Phys Rev Lett (2013) 0.82
Smoking habits in multiple system atrophy and progressive supranuclear palsy. European Study Group on Atypical Parkinsonisms. Neurology (2000) 0.81
AIDS-related non-Hodgkin's lymphomas: molecular genetics, viral infection and cytokine deregulation. Acta Haematol (1996) 0.81
Pharmacokinetic study on intravenous rifampicin in man. Pharmacol Res Commun (1984) 0.81
Antimicrobial properties of new derivatives of rifamycin SV. Antimicrob Agents Chemother (Bethesda) (1965) 0.81
In vitro activity of A-16686, a potential antiplaque agent. Antimicrob Agents Chemother (1984) 0.81
Endogenous aspartate release in the rat hippocampus is inhibited by M2 'cardiac' muscarinic receptors. Eur J Pharmacol (1990) 0.81
A genetic study of Parkinson's disease. J Neural Transm Suppl (1995) 0.81
First-trimester screening for Down syndrome using nuchal translucency measurement with free beta-hCG and PAPP-A between 10 and 13 weeks of pregnancy--the combined test. Prenat Diagn (1999) 0.81
Pseudorapidity density of charged particles in p+Pb collisions at √(s(NN))=5.02 TeV. Phys Rev Lett (2013) 0.81
Physico-chemical and biological properties of actagardine and some acid hydrolysis products. J Antibiot (Tokyo) (1985) 0.80
The common TEL/AML1 rearrangement does not represent a frequent event in acute lymphoblastic leukaemia occuring in children with Down syndrome. Leukemia (1997) 0.80
Isolation, structure determination and biological activity of A-16686 factors A' 1, A' 2 and A' 3 glycolipodepsipeptide antibiotics. J Ind Microbiol (1992) 0.80
Charge separation relative to the reaction plane in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2013) 0.80
Pion, kaon, and proton production in central Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2012) 0.80
Detection of BCL-6 rearrangements and p53 mutations in Malt-lymphomas. Am J Hematol (1997) 0.80
Synthesis and biological activity of some methyl-substituted diaminopimelic acids. Farmaco Sci (1974) 0.80
Ramoplanin (A-16686), a new glycolipodepsipeptide antibiotic. IV. Complete sequence determination by homonuclear 2D NMR spectroscopy. J Antibiot (Tokyo) (1989) 0.80
Acute myeloid leukemia (AML) having evolved from essential thrombocythemia (ET): distinctive chromosome abnormalities in patients treated with pipobroman or hydroxyurea. Leukemia (2002) 0.80
p53 gene inactivation in acute lymphoblastic leukemia of B cell lineage associates with chromosomal breakpoints at 11q23 and 8q24. Leukemia (1995) 0.80
A40926 aglycone and pseudoaglycones: preparation and biological activity. J Antibiot (Tokyo) (1988) 0.80
J/ψ polarization in pp collisions at √s=7 TeV. Phys Rev Lett (2012) 0.80
Ciliary neurotrophic factor-induced gene expression in human neuroblastoma cell lines. Neurochem Res (1995) 0.79
Distribution of TP53 mutations among acute leukemias with MLL rearrangements. Genes Chromosomes Cancer (1996) 0.79
Genetic analysis of chromosome 13 deletions in BCR/ABL negative chronic myeloproliferative disorders. Genes Chromosomes Cancer (1995) 0.79
Aberrant right subclavian artery (ARSA) in unselected population at first and second trimester ultrasonography. Prenat Diagn (2012) 0.79
Out of frame peptides from BCR/ABL alternative splicing are immunogenic in HLA A2.1 transgenic mice. Cancer Lett (2008) 0.78
Structural studies on lipiarmycin. I. Characterization by 1H and 13C NMR spectroscopy and isolation of methyl 2-O-methyl-4-O-homodichloroorsellinate-beta-rhamnoside. J Antibiot (Tokyo) (1983) 0.78
Synthesis and antibacterial activity of some derivatives of the antibiotic thermorubin. J Antibiot (Tokyo) (1985) 0.77
Etiology of Parkinson's disease. The role of environment and heredity. Adv Neurol (1996) 0.77
Phenotypic features of BHK-21 cells used for production of foot-and-mouth disease vaccine. Biologicals (1997) 0.77